Skip to main content
Top
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Autism Spectrum Disorder | Research

Urinary metabolomics using gas chromatography-mass spectrometry: potential biomarkers for autism spectrum disorder

Authors: Zaib Un Nisa Khan, Prem Chand, Hafsa Majid, Sibtain Ahmed, Aysha Habib Khan, Azeema Jamil, Saba Ejaz, Ambreen Wasim, Khaleel Ahmad Khan, Lena Jafri

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background

Diagnosis of autism spectrum disorder (ASD) is generally made phenotypically and the hunt for ASD-biomarkers continues. The purpose of this study was to compare urine organic acids profiles of ASD versus typically developing (TD) children to identify potential biomarkers for diagnosis and exploration of ASD etiology.

Methods

This case control study was performed in the Department of Pathology and Laboratory Medicine in collaboration with the Department of Pediatrics and Child Health, Aga Khan University, Pakistan. Midstream urine was collected in the first half of the day time before noon from the children with ASD diagnosed by a pediatric neurologist based on DSM-5 criteria and TD healthy controls from August 2019 to June 2021. The urine organic acids were analyzed by Gas Chromatography-Mass Spectrometry. To identify potential biomarkers for ASD canonical linear discriminant analysis was carried out for the organic acids, quantified in comparison to an internal standard.

Results

A total of 85 subjects were enrolled in the current study. The mean age of the ASD (n = 65) and TD groups (n = 20) was 4.5 ± 2.3 and 6.4 ± 2.2 years respectively with 72.3% males in the ASD group and 50% males in the TD group. Parental consanguinity was 47.7 and 30% in ASD and TD groups, respectively. The common clinical signs noted in children with ASD were developmental delay (70.8%), delayed language skills (66.2%), and inability to articulate sentences (56.9%). Discriminant analysis showed that 3-hydroxyisovalericc, homovanillic acid, adipic acid, suberic acid, and indole acetic were significantly different between ASD and TD groups. The biochemical classification results reveal that 88.2% of cases were classified correctly into ASD& TD groups based on the urine organic acid profiles.

Conclusion

3-hydroxy isovaleric acid, homovanillic acid, adipic acid, suberic acid, and indole acetic were good discriminators between the two groups. The discovered potential biomarkers could be valuable for future research in children with ASD.
Literature
1.
go back to reference Kałuzna-Czaplińska J, Socha E, Rynkowski J. Determination of homovanillic acid and vanillylmandelic acid in urine of autistic children by gas chromatography/mass spectrometry. Med Sci Monit. 2010;16(9):Cr445–50.PubMed Kałuzna-Czaplińska J, Socha E, Rynkowski J. Determination of homovanillic acid and vanillylmandelic acid in urine of autistic children by gas chromatography/mass spectrometry. Med Sci Monit. 2010;16(9):Cr445–50.PubMed
2.
go back to reference Hodges H, Fealko C, Soares N. Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation. Transl Pediatr. 2020;9(Suppl 1):S55–65.CrossRef Hodges H, Fealko C, Soares N. Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation. Transl Pediatr. 2020;9(Suppl 1):S55–65.CrossRef
3.
go back to reference Kerub O, Haas E, Menashe I, Davidovitch N, Meiri G. Autism Spectrum disorder: evolution of disorder definition, risk factors and demographic characteristics in Israel. Isr Med Assoc J. 2018;20(9):576–81.PubMed Kerub O, Haas E, Menashe I, Davidovitch N, Meiri G. Autism Spectrum disorder: evolution of disorder definition, risk factors and demographic characteristics in Israel. Isr Med Assoc J. 2018;20(9):576–81.PubMed
4.
go back to reference Kałużna-Czaplińska J, Żurawicz E, Struck W, Markuszewski M. Identification of organic acids as potential biomarkers in the urine of autistic children using gas chromatography/mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2014;966:70–6.CrossRef Kałużna-Czaplińska J, Żurawicz E, Struck W, Markuszewski M. Identification of organic acids as potential biomarkers in the urine of autistic children using gas chromatography/mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2014;966:70–6.CrossRef
5.
go back to reference Baj J, Flieger W, Flieger M, Forma A, Sitarz E, Skorzynska-Dziduszko K, et al. Autism spectrum disorder: trace elements imbalances and the pathogenesis and severity of autistic symptoms. Neurosci Biobehav Rev. 2021;129:117–32.CrossRef Baj J, Flieger W, Flieger M, Forma A, Sitarz E, Skorzynska-Dziduszko K, et al. Autism spectrum disorder: trace elements imbalances and the pathogenesis and severity of autistic symptoms. Neurosci Biobehav Rev. 2021;129:117–32.CrossRef
6.
go back to reference Dolen G, Sahin M. Editorial: essential pathways and circuits of autism pathogenesis. Front Neurosci. 2016;10:182.CrossRef Dolen G, Sahin M. Editorial: essential pathways and circuits of autism pathogenesis. Front Neurosci. 2016;10:182.CrossRef
7.
go back to reference Dong D, Zielke HR, Yeh D, Yang P. Cellular stress and apoptosis contribute to the pathogenesis of autism spectrum disorder. Autism Res. 2018;11(7):1076–90.CrossRef Dong D, Zielke HR, Yeh D, Yang P. Cellular stress and apoptosis contribute to the pathogenesis of autism spectrum disorder. Autism Res. 2018;11(7):1076–90.CrossRef
8.
go back to reference Rylaarsdam L, Guemez-Gamboa A. Genetic causes and modifiers of autism Spectrum disorder. Front Cell Neurosci. 2019;13:385.CrossRef Rylaarsdam L, Guemez-Gamboa A. Genetic causes and modifiers of autism Spectrum disorder. Front Cell Neurosci. 2019;13:385.CrossRef
9.
go back to reference Chang Y, Kim B, Youn M. Changes in children with autism Spectrum disorder after Theraplay application. Soa Chongsonyon Chongsin Uihak. 2021;32(3):112–7.PubMedPubMedCentral Chang Y, Kim B, Youn M. Changes in children with autism Spectrum disorder after Theraplay application. Soa Chongsonyon Chongsin Uihak. 2021;32(3):112–7.PubMedPubMedCentral
10.
go back to reference Kałużna-Czaplińska J, Zurawicz E, Jóźwik J. Chromatographic techniques coupled with mass spectrometry for the determination of organic acids in the study of autism. J Chromatogr B Anal Technol Biomed Life Sci. 2014;964:128–35.CrossRef Kałużna-Czaplińska J, Zurawicz E, Jóźwik J. Chromatographic techniques coupled with mass spectrometry for the determination of organic acids in the study of autism. J Chromatogr B Anal Technol Biomed Life Sci. 2014;964:128–35.CrossRef
11.
go back to reference Arinda A, Nakasujja N, Odokonyero R. Prevalence of autism spectrum disorder symptoms in a paediatric neurology clinic at a tertiary hospital in Uganda. S Afr J Psychiatry. 2021;27:1548. Arinda A, Nakasujja N, Odokonyero R. Prevalence of autism spectrum disorder symptoms in a paediatric neurology clinic at a tertiary hospital in Uganda. S Afr J Psychiatry. 2021;27:1548.
12.
go back to reference Blaxill M, Rogers T, Nevison C. Autism tsunami: the impact of rising prevalence on the societal cost of autism in the United States. J Autism Dev Disord. 2021. Blaxill M, Rogers T, Nevison C. Autism tsunami: the impact of rising prevalence on the societal cost of autism in the United States. J Autism Dev Disord. 2021.
13.
go back to reference Brondino N, Bertoglio F, Forneris F, Faravelli S, Borghesi A, Damiani S, et al. A pilot study on Covid and autism: prevalence, clinical presentation and vaccine side effects. Brain Sci. 2021;11(7). Brondino N, Bertoglio F, Forneris F, Faravelli S, Borghesi A, Damiani S, et al. A pilot study on Covid and autism: prevalence, clinical presentation and vaccine side effects. Brain Sci. 2021;11(7).
14.
go back to reference Sabbagh HJ, Al-Jabri BA, Alsulami MA, Hashem LA, Aljubour AA, Alamoudi RA. Prevalence and characteristics of autistic children attending autism centres in 2 major cities in Saudi Arabia: a cross-sectional study. Saudi Med J. 2021;42(4):419–27.CrossRef Sabbagh HJ, Al-Jabri BA, Alsulami MA, Hashem LA, Aljubour AA, Alamoudi RA. Prevalence and characteristics of autistic children attending autism centres in 2 major cities in Saudi Arabia: a cross-sectional study. Saudi Med J. 2021;42(4):419–27.CrossRef
15.
go back to reference Sun X, Allison C, Matthews FE, Sharp SJ, Auyeung B, Baron-Cohen S, Brayne C. Prevalence of autism in mainland China, Hong Kong and Taiwan: a systematic review and meta-analysis. Molecular autism. 2013;4(1):1-3. Sun X, Allison C, Matthews FE, Sharp SJ, Auyeung B, Baron-Cohen S, Brayne C. Prevalence of autism in mainland China, Hong Kong and Taiwan: a systematic review and meta-analysis. Molecular autism. 2013;4(1):1-3.
16.
go back to reference Fuentes J, Basurko A, Isasa I, Galende I, Muguerza MD, Garcia-Primo P, et al. The ASDEU autism prevalence study in northern Spain. Eur Child Adolesc Psychiatry. 2021;30(4):579–89.CrossRef Fuentes J, Basurko A, Isasa I, Galende I, Muguerza MD, Garcia-Primo P, et al. The ASDEU autism prevalence study in northern Spain. Eur Child Adolesc Psychiatry. 2021;30(4):579–89.CrossRef
17.
go back to reference Wang F, Lu L, Wang SB, Zhang L, Ng CH, Ungvari GS, Cao XL, Lu JP, Hou CL, Jia FJ, Xiang YT. The prevalence of autism spectrum disorders in China: a comprehensive meta-analysis. International journal of biological sciences. 2018;14(7):717. Wang F, Lu L, Wang SB, Zhang L, Ng CH, Ungvari GS, Cao XL, Lu JP, Hou CL, Jia FJ, Xiang YT. The prevalence of autism spectrum disorders in China: a comprehensive meta-analysis. International journal of biological sciences. 2018;14(7):717.
18.
go back to reference Khalid M, Raza H, M Driessen T, J Lee P, Tejwani L, Sami A, Nawaz M, Mehmood Baig S, Lim J, Kaukab Raja G. Genetic risk of autism spectrum disorder in a Pakistani population. Genes. 2020;11(10):1206. Khalid M, Raza H, M Driessen T, J Lee P, Tejwani L, Sami A, Nawaz M, Mehmood Baig S, Lim J, Kaukab Raja G. Genetic risk of autism spectrum disorder in a Pakistani population. Genes. 2020;11(10):1206.
19.
go back to reference Durkin MS, Wolfe BL. Trends in autism prevalence in the U.S.: a lagging economic Indicator? J Autism Dev Disord. 2020;50(3):1095–6.CrossRef Durkin MS, Wolfe BL. Trends in autism prevalence in the U.S.: a lagging economic Indicator? J Autism Dev Disord. 2020;50(3):1095–6.CrossRef
20.
go back to reference Zhang ZC, Han J. The first National Prevalence of autism Spectrum disorder in China. Neurosci Bull. 2020;36(9):959–60.CrossRef Zhang ZC, Han J. The first National Prevalence of autism Spectrum disorder in China. Neurosci Bull. 2020;36(9):959–60.CrossRef
21.
go back to reference Delobel-Ayoub M, Saemundsen E, Gissler M, Ego A, Moilanen I, Ebeling H, et al. Prevalence of autism Spectrum disorder in 7-9-year-old children in Denmark, Finland, France and Iceland: a population-based registries approach within the ASDEU project. J Autism Dev Disord. 2020;50(3):949–59.CrossRef Delobel-Ayoub M, Saemundsen E, Gissler M, Ego A, Moilanen I, Ebeling H, et al. Prevalence of autism Spectrum disorder in 7-9-year-old children in Denmark, Finland, France and Iceland: a population-based registries approach within the ASDEU project. J Autism Dev Disord. 2020;50(3):949–59.CrossRef
22.
go back to reference Honda H, Shimizu Y, Misumi K, Niimi M, Ohashi Y. Cumulative incidence and prevalence of childhood autism in children in Japan. Br J Psychiatry. 1996;169(2):228–35.CrossRef Honda H, Shimizu Y, Misumi K, Niimi M, Ohashi Y. Cumulative incidence and prevalence of childhood autism in children in Japan. Br J Psychiatry. 1996;169(2):228–35.CrossRef
23.
go back to reference Li J, You Y, Yue W, Jia M, Yu H, Lu T, et al. Genetic evidence for possible involvement of the Calcium Channel gene CACNA1A in autism pathogenesis in Chinese Han population. PLoS One. 2015;10(11):e0142887.CrossRef Li J, You Y, Yue W, Jia M, Yu H, Lu T, et al. Genetic evidence for possible involvement of the Calcium Channel gene CACNA1A in autism pathogenesis in Chinese Han population. PLoS One. 2015;10(11):e0142887.CrossRef
24.
go back to reference Furrukh J, Anjum G. Coping with Autism spectrum disorder (ASD) in Pakistan: A phenomenology of mothers who have children with ASD. Cogent Psychology. 2020;7(1):1728108. Furrukh J, Anjum G. Coping with Autism spectrum disorder (ASD) in Pakistan: A phenomenology of mothers who have children with ASD. Cogent Psychology. 2020;7(1):1728108.
25.
go back to reference Nadeem G, Bibi A, Suhaib B, Ahmed S, Ali S. Clinical and demographic features of 76 children with autism spectrum disorders at a centre in Pakistan. Journal of the College of Physicians and Surgeons Pakistan. 2019;29(4):390-1. Nadeem G, Bibi A, Suhaib B, Ahmed S, Ali S. Clinical and demographic features of 76 children with autism spectrum disorders at a centre in Pakistan. Journal of the College of Physicians and Surgeons Pakistan. 2019;29(4):390-1.
26.
go back to reference Minhas A, Vajaratkar V, Divan G, Hamdani SU, Leadbitter K, Taylor C, Aldred C, Tariq A, Tariq M, Cardoza P, Green J. Parents’ perspectives on care of children with autistic spectrum disorder in South Asia–Views from Pakistan and India. International Review of Psychiatry. 2015;27(3):247-56. Minhas A, Vajaratkar V, Divan G, Hamdani SU, Leadbitter K, Taylor C, Aldred C, Tariq A, Tariq M, Cardoza P, Green J. Parents’ perspectives on care of children with autistic spectrum disorder in South Asia–Views from Pakistan and India. International Review of Psychiatry. 2015;27(3):247-56.
27.
go back to reference Jones PM, Bennett MJ. Urine organic acid analysis for inherited metabolic disease using gas chromatography-mass spectrometry. Methods Mol Biol. 2010;603:423–31.CrossRef Jones PM, Bennett MJ. Urine organic acid analysis for inherited metabolic disease using gas chromatography-mass spectrometry. Methods Mol Biol. 2010;603:423–31.CrossRef
28.
go back to reference Goldani AA, Downs SR, Widjaja F, Lawton B, Hendren RL. Biomarkers in autism. Frontiers in psychiatry. 2014;5:100. Goldani AA, Downs SR, Widjaja F, Lawton B, Hendren RL. Biomarkers in autism. Frontiers in psychiatry. 2014;5:100.
29.
go back to reference Kumps A, Duez P, Mardens Y. Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. Clin Chem. 2002;48(5):708–17.PubMed Kumps A, Duez P, Mardens Y. Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. Clin Chem. 2002;48(5):708–17.PubMed
30.
go back to reference Page TJJoa, Disorders d. metabolic approaches to the treatment of autism spectrum disorders. 2000;30(5):463–469. Page TJJoa, Disorders d. metabolic approaches to the treatment of autism spectrum disorders. 2000;30(5):463–469.
31.
go back to reference Manzi B, Loizzo AL, Giana G, Curatolo P. Autism and metabolic diseases. Journal of child neurology. 2008;23(3):307-14. Manzi B, Loizzo AL, Giana G, Curatolo P. Autism and metabolic diseases. Journal of child neurology. 2008;23(3):307-14.
32.
go back to reference Noto A, Fanos V, Barberini L, Grapov D, Fattuoni C, Zaffanello M, et al. The urinary metabolomics profile of an Italian autistic children population and their unaffected siblings. J Matern Fetal Neonatal Med. 2014;27(Suppl 2):46–52.CrossRef Noto A, Fanos V, Barberini L, Grapov D, Fattuoni C, Zaffanello M, et al. The urinary metabolomics profile of an Italian autistic children population and their unaffected siblings. J Matern Fetal Neonatal Med. 2014;27(Suppl 2):46–52.CrossRef
33.
go back to reference Kałużna-Czaplińska J, Socha E, Rynkowski JJNr. B vitamin supplementation reduces excretion of urinary dicarboxylic acids in autistic children. 2011;31(7):497–502. Kałużna-Czaplińska J, Socha E, Rynkowski JJNr. B vitamin supplementation reduces excretion of urinary dicarboxylic acids in autistic children. 2011;31(7):497–502.
34.
go back to reference Gevi F, Belardo A, Zolla L. A metabolomics approach to investigate urine levels of neurotransmitters and related metabolites in autistic children. Biochim Biophys Acta Mol Basis Dis. 2020;1866(10):165859.CrossRef Gevi F, Belardo A, Zolla L. A metabolomics approach to investigate urine levels of neurotransmitters and related metabolites in autistic children. Biochim Biophys Acta Mol Basis Dis. 2020;1866(10):165859.CrossRef
35.
go back to reference Gevi F, Zolla L, Gabriele S, Persico AM. Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism. Molecular autism. 2016;7(1):1-1. Gevi F, Zolla L, Gabriele S, Persico AM. Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism. Molecular autism. 2016;7(1):1-1.
36.
go back to reference Padulo J, Oliva F, Frizziero A, Maffulli N. Basic principles and recommendations in clinical and field science research: 2018 update; 2018. Padulo J, Oliva F, Frizziero A, Maffulli N. Basic principles and recommendations in clinical and field science research: 2018 update; 2018.
37.
go back to reference Coury DL. DSM-5 and autism spectrum disorders: implications for families and clinicians. J Dev Behav Pediatr. 2013;34(7):494–6.CrossRef Coury DL. DSM-5 and autism spectrum disorders: implications for families and clinicians. J Dev Behav Pediatr. 2013;34(7):494–6.CrossRef
38.
go back to reference Yap IK, Angley M, Veselkov KA, Holmes E, Lindon JC, Nicholson JK. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res. 2010;9(6):2996–3004.CrossRef Yap IK, Angley M, Veselkov KA, Holmes E, Lindon JC, Nicholson JK. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res. 2010;9(6):2996–3004.CrossRef
39.
go back to reference Baxmann AC, Ahmed MS, Marques NC, Menon VB, Pereira AB, Kirsztajn GM, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol. 2008;3(2):348–54.CrossRef Baxmann AC, Ahmed MS, Marques NC, Menon VB, Pereira AB, Kirsztajn GM, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol. 2008;3(2):348–54.CrossRef
40.
go back to reference Puig-Alcaraz C, Fuentes-Albero M, Cauli O. Relationship between adipic acid concentration and the core symptoms of autism spectrum disorders. Psychiatry Res. 2016;242:39–45.CrossRef Puig-Alcaraz C, Fuentes-Albero M, Cauli O. Relationship between adipic acid concentration and the core symptoms of autism spectrum disorders. Psychiatry Res. 2016;242:39–45.CrossRef
41.
go back to reference Vianey-Liaud C, Divry P, Gregersen N, Mathieu M. The inborn errors of mitochondrial fatty acid oxidation. J Inherit Metab Dis. 1987;10(Suppl 1):159–200.CrossRef Vianey-Liaud C, Divry P, Gregersen N, Mathieu M. The inborn errors of mitochondrial fatty acid oxidation. J Inherit Metab Dis. 1987;10(Suppl 1):159–200.CrossRef
42.
go back to reference Gong Z, Liang L, Qiu W, Zhang H, Ye J, Wang Y, et al. Clinical, biochemical, and molecular analyses of medium-chain acyl-CoA dehydrogenase deficiency in Chinese patients. Front Genet. 2021;12:577046.CrossRef Gong Z, Liang L, Qiu W, Zhang H, Ye J, Wang Y, et al. Clinical, biochemical, and molecular analyses of medium-chain acyl-CoA dehydrogenase deficiency in Chinese patients. Front Genet. 2021;12:577046.CrossRef
43.
go back to reference Chapel-Crespo C, Gavrilov D, Sowa M, Myers J, Day-Salvatore DL, Lynn H, et al. Clinical, biochemical and molecular characteristics of malonyl-CoA decarboxylase deficiency and long-term follow-up of nine patients. Mol Genet Metab. 2019;128(1–2):113–21.CrossRef Chapel-Crespo C, Gavrilov D, Sowa M, Myers J, Day-Salvatore DL, Lynn H, et al. Clinical, biochemical and molecular characteristics of malonyl-CoA decarboxylase deficiency and long-term follow-up of nine patients. Mol Genet Metab. 2019;128(1–2):113–21.CrossRef
44.
go back to reference Yu JL, Xia XX, Zhong JJ, Qian ZG. Direct biosynthesis of adipic acid from a synthetic pathway in recombinant Escherichia coli. Biotechnol Bioeng. 2014;111(12):2580–6.CrossRef Yu JL, Xia XX, Zhong JJ, Qian ZG. Direct biosynthesis of adipic acid from a synthetic pathway in recombinant Escherichia coli. Biotechnol Bioeng. 2014;111(12):2580–6.CrossRef
45.
go back to reference Ding HT, Taur Y. Walkup JTJJoa, disorders d. Gut Microbiota Autism Key Concepts Find. 2017;47(2):480–9. Ding HT, Taur Y. Walkup JTJJoa, disorders d. Gut Microbiota Autism Key Concepts Find. 2017;47(2):480–9.
46.
go back to reference de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr. 2010;51(4):418–24.CrossRef de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr. 2010;51(4):418–24.CrossRef
47.
go back to reference Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA. Gastrointestinal flora and gastrointestinal status in children with autism--comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011;11:22.CrossRef Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA. Gastrointestinal flora and gastrointestinal status in children with autism--comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011;11:22.CrossRef
48.
go back to reference Daneberga Z, Nakazawa-Miklasevica M, Berga-Svitina E, Isarova D, Cupane L, Masinska M, Nartisa I, Lazdane A, Miklasevics E. Urinary organic acids spectra in children with altered gut microbiota composition and autistic spectrum disorder. Nordic Journal of Psychiatry. 2021;1-7. Daneberga Z, Nakazawa-Miklasevica M, Berga-Svitina E, Isarova D, Cupane L, Masinska M, Nartisa I, Lazdane A, Miklasevics E. Urinary organic acids spectra in children with altered gut microbiota composition and autistic spectrum disorder. Nordic Journal of Psychiatry. 2021;1-7.
49.
go back to reference Kałużna-Czaplińska J. Noninvasive urinary organic acids test to assess biochemical and nutritional individuality in autistic children. Clin Biochem. 2011;44(8–9):686–91.CrossRef Kałużna-Czaplińska J. Noninvasive urinary organic acids test to assess biochemical and nutritional individuality in autistic children. Clin Biochem. 2011;44(8–9):686–91.CrossRef
50.
go back to reference Pavăl D. A dopamine hypothesis of autism spectrum disorder. Developmental neuroscience. 2017;39(5):355-60. Pavăl D. A dopamine hypothesis of autism spectrum disorder. Developmental neuroscience. 2017;39(5):355-60.
51.
go back to reference Lelord G, Callaway E, Muh JP, Arlot JC, Sauvage D, Garreau B, et al. Modifications in urinary homovanillic acid after ingestion of vitamin B6; functional study in autistic children (author's transl). Rev Neurol. 1978;134(12):797–801.PubMed Lelord G, Callaway E, Muh JP, Arlot JC, Sauvage D, Garreau B, et al. Modifications in urinary homovanillic acid after ingestion of vitamin B6; functional study in autistic children (author's transl). Rev Neurol. 1978;134(12):797–801.PubMed
52.
go back to reference Nye C, Brice AJCDoSR. Combined vitamin B6-magnesium treatment in autism spectrum disorder, vol. 4; 2005. Nye C, Brice AJCDoSR. Combined vitamin B6-magnesium treatment in autism spectrum disorder, vol. 4; 2005.
53.
go back to reference Khan F, Rahman MS, Akhter S, Momen AB, Raihan SG. Vitamin B6 and magnesium on neurobehavioral status of autism spectrum disorder: a randomized, double-blind, placebo controlled study. Bangladesh Journal of Medicine. 2021;32(1):12-8. Khan F, Rahman MS, Akhter S, Momen AB, Raihan SG. Vitamin B6 and magnesium on neurobehavioral status of autism spectrum disorder: a randomized, double-blind, placebo controlled study. Bangladesh Journal of Medicine. 2021;32(1):12-8.
Metadata
Title
Urinary metabolomics using gas chromatography-mass spectrometry: potential biomarkers for autism spectrum disorder
Authors
Zaib Un Nisa Khan
Prem Chand
Hafsa Majid
Sibtain Ahmed
Aysha Habib Khan
Azeema Jamil
Saba Ejaz
Ambreen Wasim
Khaleel Ahmad Khan
Lena Jafri
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02630-4

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue